Try our Advanced Search for more refined results
AngioDynamics, Inc. v. Biolitec AG et al
Case Number:
3:09-cv-30181
Court:
Nature of Suit:
Judge:
Firms
- Cooley Shrair
- Doherty Wallace
- Egan Flanagan
- Eiseman Levine
- Jager Smith
- Mazzotta & Vagianelis
- Nixon Peabody
- Pachulski Stang
Companies
Sectors & Industries:
-
May 16, 2018
Biolitec Counsel Can't Dodge Sanction For Stonewalling
A federal judge in Massachusetts on Wednesday refused to reconsider a sanction he imposed against specialty laser firm Biolitec AG for what the judge has called the company's "ethically dubious" tactics and "shameless stonewalling" in its decadelong fight against liability for a subsidiary's multimillion-dollar patent infringement settlement.
-
April 26, 2018
Atty Cites 1st Circ. In Seeking Contempt In Biolitec IP Case
An attorney asked a Massachusetts federal judge Wednesday to reconsider ordering him to pay a nearly $50,000 sanction for trying to help client Biolitec AG dodge a $75 million judgment won by AngioDynamics Inc. in a years-old intellectual property dispute, saying he was following the First Circuit's direction in seeking a contempt order.
-
March 30, 2018
Co. Punished For Dodging Discovery Tied To $75M IP Loss
A Massachusetts federal judge on Thursday blasted Biolitec AG, its leader and local counsel for making it nearly impossible for AngioDynamics Inc. to collect on a years-old $75 million judgment in an IP dispute, ordering monthly sanctions that could add up to $1 million total until it complies with a discovery order.
-
April 24, 2015
Biolitec's Contempt Fine Capped At $70M In IP Dispute
A Massachusetts federal judge on Wednesday capped contempt sanctions against an affiliate of Biolitec AG at $70 million in a patent dispute, saying the amount was a "reasonable penalty" to induce the German laser company to comply with the court's preliminary injunction forbidding it to merge with an Austrian company.
-
April 08, 2015
Biolitec Exec Still Ducking Depositions, Sanctions Bid Says
AngioDynamics Inc. on Wednesday urged a Massachusetts federal judge to sanction a group of Biolitec AG affiliates for its CEO's repeated refusal to show up for depositions, arguing the companies should be forced to pay a $75 million judgment entered against Biolitec last year.
-
March 18, 2014
Biolitec Hit With $75M Judgment In IP Indemnification Feud
A Massachusetts federal judge on Tuesday ordered Biolitec AG and affiliates to pay $75 million in damages for failing to shield AngioDynamics Inc. from patent infringement claims related to varicose vein treatments, just after entering default judgment against the defendants on the issue of liability.
-
February 11, 2014
Biolitec Appeals $63M Sanction, CEO Arrest Order In IP Row
Biolitec AG on Monday asked the First Circuit to overturn a district court ruling that stuck the German laser company with $63 million in contempt damages and an arrest warrant for its CEO, saying it hadn't caused any damage to the plaintiff in an intellectual property indemnification suit by completing a planned merger.
-
September 24, 2013
AngioDynamics Renews Bid For Biolitec Sanctions In IP Row
Medical device manufacturer AngioDynamics Inc. on Monday renewed its bid for sanctions against German laser firm Biolitec AG in its intellectual property indemnification suit against the company, arguing that it has continued to defy court orders by failing to produce three critical witnesses.
-
August 30, 2013
Biolitec Escapes Additional Sanctions In AngioDynamics Row
A Massachusetts federal judge on Friday declined to levy additional sanctions against specialty laser firm Biolitec AG and owner Biomed Technology Holdings Co. for their alleged noncompliance with earlier court orders stemming from an improper merger in an intellectual property indemnification suit brought by AngioDynamics Inc.
-
August 27, 2013
Biolitec Loses Bid To DQ Judge In AngioDynamics Row
A Massachusetts federal judge on Tuesday refused to disqualify himself from an intellectual property dispute between German medical laser maker Biolitec AG and medical device manufacturer AngioDynamics Inc., saying his disapproval of Biolitec's bad behavior was not grounds for recusal.